Abbreviations used: NADH, nicotinamide adenine dinucleo tide (reduced form).
Summary: The effects of two prostaglandin synthesis in hibitors on brain oxidative metabolism and cerebral blood volume were studied by the nicotinamide adenine dinucleotide (reduced) (NADH) fluorescence technique in rats, Indomethacin (5, 10, and 15 mg/kg) and sodium salicylate (50, 100, and 300 mg/kg) were administered in travenously to groups of rats anesthetized with either ni trous oxide or pentobarbital (40 mg/kg, i.p.). The effects of pentobarbital alone were also examined: pentobarbital induced a progressive reduction in blood volume 4 min following intraperitoneal administration. A reduced NADH fluorescence (oxidation) was noted approxi mately 9 min after pentobarbital treatment. In N20-anes thetized rats, the effects of salicylate were dose-depen dent. Low doses (50 and 100 mg/kg) decreased both blood volume and NADH fluorescence; in contrast, salic ylate at 300 mg/kg increased blood volume and NADH fluorescence. Following pentobarbital, the effects of sa licylate (50 and 100 mg/kg) were reversed: increases in both blood volume and NADH fluorescence were seen. In the absence of pentobarbital, it would appear that sa-Ever since the initial study of Pickard and MacKenzie (1973) showing that indomethacin de creased cerebral blood flow and antagonized the CO2-induced relaxation of vascular smooth muscle, these observations have been amply confirmed in various species by a number of investigators (see Pickard, 1981) . The mechanisms by which the in domethacin-induced vasoconstriction takes place remain unclear, as indomethacin is devoid of ac tivity when isolated cerebral vessels are studied in vitro (Chapleau et aI. , 1980; Pickard, 1981) . Thus, a licylate induces a cerebral vasoconstriction, an effect that may be obscured by a central stimulation provoked by this drug. Under N20 anesthesia, indomethacin, in a dose-related manner, induced a decrease in blood volume that was accompanied by a dose-related increase in NADH fluorescence (reduction). The changes induced by the highest dose of indomethacin (15 mg/kg) were es sentially abolished by pentobarbital. These results sup port those studies in which indomethacin-induced cere bral vasoconstriction could be abolished by barbiturates. Furthermore, our experiments demonstrate, following in domethacin infusion, a decrease in brain oxidative me tabolism. With indomethacin, the NADH fluorescence technique would suggest that the metabolic effects of this drug are essentially to reduce oxygen consumption without any noticeable effect on glucose utilization; the observed changes in cerebral perfusion are likely to be directly correlated with the decreases in cerebral oxygen consumption. Key Words: Barbiturate anesthesia-Brain metabolism-Cerebral blood volume-NADH fluores cence in vivo-Prostaglandin synthesis inhibitors.
direct vascular effect appears unlikely. Secondly, the decrease in cerebral perfusion following indo methacin infusion is unlikely to be secondary to a decreased brain metabolism as the drug-induced decrease in cerebral blood flow is not accompanied by any significant changes in cerebral metabolic rate for glucose (McCulloch et aI. , 1982) , nor is the cerebral oxygen consumption rate significantly modified in most of the previous studies (Pickard and MacKenzie, 1973; Dahlgren et ai. , 1981) , al though it has been shown that this latter index of cerebral metabolism might decrease following indo methacin administration (Pickard et aI. , 1980a; Dahlgren and Siesjo, 1981) .
It has been hypothesized that the reduction in ce rebral blood flow following indomethacin infusion might be related to an inhibition of prostaglandin synthesis (Pickard and MacKenzie, 1973; Pickard, 1981) . Although both indomethacin and salicylate share this last property (Vane, ]971; Abdel-Halim et al., 1978) , there appear to be major differences between these two drugs. In fact, a primate study has demonstrated that salicylate did not decrease basal blood flow and had a very minor effect on the cerebrovascular response to increased CO2 tension (Pickard et ai. , 1980b) . Furthermore, large in creases in cerebral oxygen consumption were noted following the infusion of salicylate (Pickard et al., 1980b) . However, in a further study, it was shown that in awake rats, the infusion of lysine acetylsa licylate was equipotent to indomethacin in de creasing cerebral blood flow (Quintana et al. , 1983) . The discrepancy between the vascular and meta bolic effects of indomethacin and salicylate were thus tentatively explained by a concomitant central stimulation induced by the latter drug (Pickard et ai., 1980b) .
The conflicting results presented above were ob tained with techniques that only allow endpoint de terminations (e .g., autoradiography) or discon tinuous measurements of blood flow or oxygen consumption. In the present study, we tried to ob viate discrete observations of time-related drug changes through the use of the noninvasive moni toring of metabolism in situ developed by Chance and J6bsis (1959) . Their technique provides a con tinuous recording of changes in redox level of intra mitochondrial nicotinamide adenine dinucleotide (NADH), as the reduced form of this coenzyme flu oresces, unlike the oxidized form (NAD+ ). These measurements reflect modifications in mitochon drial activity in the intact brain. Moreover, the si multaneous recording of cerebral blood volume might allow a better understanding of temporal changes in cerebral blood supply.
In the present investigation, NADH fluorescence and cortical blood volume were measured in ni trous oxide-or pentobarbital-anesthetized rats under controlled physiological conditions. The met abolic and circulatory effects of various doses of indomethacin and salicylate were studied, and the effects of pentobarbital alone were also investi gated.
MATERIALS AND METHODS

Optical techniques
The monitoring of redox changes in NADH at the sur face of the cerebral cortex was performed with a CF2 fluorometer (Johnson Research Foundation, University of Pennsylvania, Philadelphia, PA, U.S.A.), which was modified so as to increase the sensitivity. The 366-nm ex citation light from a 100-W mercury lamp was focused on one branch of a Y -shaped light guide, the common part being apposed to the dural surface. Reflected 366-nm ex citation light (R) and 450-nm tissue fluorescence (F) were collected in the second branch of the light guide and mea sured by separate photomultipliers. Both signals are af fected equally by blood volume changes, and thus, a more accurate indicator of the NADH redox level is the difference between the reflectance and the fluorescence signals: F -R = CF (corrected fluorescence). Changes in the reflectance signal are closely related to changes in blood volume (Dora and Kovach, 1982) . Several lines of evidence indicate that the labile fluorescence signal is at tributable to the intramitochondrial NADH fraction, with a negligible contribution from cytoplasmatic NADH (O'Connor, 1976) . The signal is derived from the upper 1 mm of the cortex surface (Chance et aI., 1962 (Chance et aI., , J6bsis et aI., 1971 .
Calibration of the fluorometer was performed as follows: 0 is the value obtained when no light enters into the photomultiplier tube, and 100% is the value recorded initially in the basal state. Thus, the values reported do not represent a percent difference between two absolute values, but a relative difference from the resting level.
Surgical procedure
All experiments were performed on 58 male Wi star rats (Iffa-Credo Laboratories), weighing 260-280 g. The an imals had free access to commercial food pellets and water prior to experimentation. The rats were first anes thetized with halothane, and following tracheotomy and immobilization (alcuronium chloride, 10 mg/kg, i.p.), the rats were artificially ventilated (0.6-0.8% halothane in 30% Ozl70% NzO). Both femoral arteries and one femoral vein were cannulated. The heads of the rats were fixed in a stereotaxic frame, and the calvarium was exposed by a longitudinal incision of the scalp. All surgical incisions were infiltrated with local anesthetic (xylocaine). A 5-mm diameter craniectomy was then performed over the left parietal cortex. Care was taken to leave the dura mater intact and bloodless. The exposed surface was then cov ered with mineral oil, and the tip of the optic fibers ap posed to the dural surface. Following the surgical prepa ration, the halothane was discontinued, and the rats were allowed to recover for a period of 30 min prior to drug administration. Mean arterial pressure and body temper ature were monitored throughout the experimental pe riod. Samples of arterial blood were withdrawn for deter mination of pH, P02, Pe02, and plasma glucose levels. These samples were taken just before and 10 and 25 min after drug administration.
Drug administration
Indomethacin was dissolved in a sodium bicarbonate solution, and the final pH was adjusted to approximately 7.4 with hydrochloric acid. In N20I02-anesthetized rats, three doses of indomethacin were given intravenously in different groups of rats: 5 mg/kg, 10 mg/kg, and 15 mg/kg. The rate of administration was 1 mUmin and, to avoid changes in optical signals caused by hemodilution, the volume of injection was kept below 0.3 ml.
The same administration procedure was followed for sodium salicylate (dissolved in water) for the lowest dose studied (50 mg/kg). However, both 100 and 300 mg/kg of salicylate were injected over 5 min, due to the large meta bolic problems encountered with rapid administration (see Results). After administration of salicylate, exces-i.-P. NOWICKI ET AL. sive bleeding below the light guide occurred only rarely. In that instance, as the presence of blood would preclude any optical measurements to be performed, the experi ment was discarded.
In all instances, the intravenous infusion of drugs was initiated 30 min after halothane had been discontinued, including those rats to which pentobarbital was adminis tered intraperitoneally. In barbiturate-anesthetized an imals, indomethacin and salicylate were injected 20 min after administration of barbiturate and after a new cali bration was performed (see Optical techniques). In these groups of rats, the drug-induced changes were compared to the signals obtained under pentobarbital anesthesia alone.
Statistical analysis
Results were analyzed using Student's t test, com paring, at each time, mean values in treated rats to the corresponding matched time-related mean values in sa line-injected rats.
RESULTS
Physiological parameters
The infusion of indomethacin in N20/02-anesthe tized rats did not induce any changes in Po2, Peo2, pH, body temperature, or plasma glucose. Baseline parameters for indomethacin-infused rats are re ported in Table 1 .
Under this anesthetic regimen, the infusion of in domethacin was immediately followed, at all doses tested, by a decrease in mean arterial pressure that remained statistically nonsignificant (15 mg/kg: -11. 5 mm Hg). Later on, a significant increase in mean arterial pressure values was noted. However, this effect was short-lasting, as the values were not different from control 1 min after indomethacin in fusion. After pentobarbital anesthesia, the physio logical parameters were not modified following in domethacin administration throughout the study.
However, the transient indomethacin-induced hy potension was more marked (15 mg/kg: -40 mm Hg), but again, the values returned to control levels within seconds.
Ten minutes after salicylate infusion, consistent changes in respiratory parameters occurred that were significant for the highest dose administered (Table 2) . Following 300 mg/kg of salicylate, a large increase in Peo2 was noted, which was accompa nied by a shift of blood pH toward acidic values and a decrease in blood Po2• Simultaneously, body tem perature rose, as did plasma glucose levels. In pre liminary experiments, the rapid administration of 100 mg/kg and 300 mg/kg of salicylate induced ma jor respiratory and cardiovascular changes, fol lowed, in a large number of rats, by death. Thus, the design of the injection procedure was changed for a slow infusion over 5 min (see Materials and Methods) . Under those conditions, the effects were partially circumvented, but even so, it was difficult to maintain normocapnia. Twenty-five minutes after drug infusion, most of these salicylate-induced physiological changes remained modified (Table 2) . Systemic arterial pressure was not affected at any time by salicylate infusion.
In barbiturate-anesthetized animals, physiolog ical values, at all doses, were within the physiolog ical range and remained constant throughout the study. Baseline parameters for pentobarbital treated rats are reported in Table 1 .
Optical changes
In control saline-treated rats (N20-anesthetized), corrected fluorescence showed only slight changes that were not statistically different when compared to initial values over the 30-min period of observa tion. Data are means ± SE and represent the values before drug administration. There were no significant differ ences between control values in saline-injected rats and any value in treated rats, nor were there any time-re lated significant differences in control rats. Data are means:': SE and represent the values before and then 10 min and 25 min after either saline or drug infusion. At each time considered. the values for salicylate-injected rats were compared to time-matched corresponding control values in saline-injected rats (see Table I ).
Statistical significance: "p < 0.05; bp < 0.01.
Pentobarbital
The administration of pentobarbital (40 mg/kg, i.p.) induced a time-dependent decrease in blood volume that plateaued after 10 min, although the delay of onset and the absolute decrease differed from rat to rat. A significant decrease in mean blood volume values was first obtained 4 min after pentobarbital administration (Fig. 1) . The corrected fluorescence signal indicated a sustained and signif icant NADH oxidation after 10 min, which was preceded by a short initial reduction phase (Fig. I) that occurred simultaneously with the decrease III blood volume.
Indomethacin
In N20-anesthetized rats, a rapid increase in cor rected fluorescence was observed shortly after in domethacin infusion (Fig. 2) . The NAD reduction appeared to be dose-dependent and peaked at 20 s (Fig. 3A) . The indomethacin-induced changes in corrected fluorescence were maintained constant thereafter over the 30-min duration of the experi ment. Simultaneous with the changes in the meta bolic optical signal, a decrease in blood volume oc curred in a biphasic manner (Fig. 3B ). The first phase of blood volume decrease occurred at the time when the increase in corrected fluorescence was observed (20 s) and when the decrease in mean arterial pressure was the highest. However, a sec ondary decrease in blood volume occurred in a time-dependent manner, when the induced changes in metabolism had already stabilized (Fig. 2) . A plateau was reached between 2 and 5 min following administration, and the magnitude of the absolute decrease was double that obtained at 20 s. This pla teau remained stable during the 30-min duration of the study, following 5 and 10 mg/kg indomethacin. At the highest dose of indomethacin administered (15 mg/kg), blood volume slowly increased toward baseline values after 15 min.
After pentobarbital anesthesia, the infusion of in domethacin at the highest dose (15 mg/kg) rapidly induced a transient, but significant, increase in NAD reduction, followed by a decrease to baseline values within seconds (Fig. 3A) . Thereafter, a slow increase in the metabolic signal developed that was not statistically significant (Fig. 2) . In the barbitu rate-treated rats, the injection of indomethacin failed to effect any significant change 10 blood volume (Fig. 2) .
Salicylate
Under NzOIOz anesthesia, the infusion of 50 and 100 mg/kg of sodium salicylate induced a slow oxi dation of NADH that became significant after 25 min (Fig. 4 ). There were no significant differences between the two doses, a fact perhaps related to pharmacokinetics, as the rate of injection differed between the two doses (see Materials and Methods). Following the infusion of 300 mg/kg of salicylate, the redox signal tended to be reduced, although not significantly (Fig. 4 ). Under the same anesthetic regimen, salicylate at 50 mg/kg and 100 mg/kg decreased blood volume in a dose-related manner-an effect that was only significant with 100 mg/kg (Fig. 4) . In contrast, the highest dose of salicylate tested (300 mg/kg) increased blood volume, although not significantly (Fig. 4) .
Under pentobarbital anesthesia, the infusion of salicylate, both at 50 mg/kg and 100 mg/kg, induced a significant increase in blood volume (Fig. 5) . The study of the metabolic signal indicated that after an initial period where NADH was more oxidized, a late reduction phase was evident that was signifi cant only after 50 mg/kg of salicylate (Fig. 5 ).
DISCUSSION
Numerous studies strongly suggest that the changes in cortical NADH fluorescence levels in vivo are indicative of mitochondrial activity in the intact brain. This conclusion was drawn from ex periments in which an NADH oxidation was de tected in situations of increased neuronal activity, such as seizures (lobsis et aI., 197 1), evoked poten tials (Rosenthal and lobsis, 197 1) , and spreading depression (Rosenthal and Somjen, 1973) . How ever, an increase in NADH oxidation can be ob served during hypoglycemia, a state in which there is a decreased supply of reducing equivalents (Bryan and lobsis, 1983) . Increased NADH oxida tion is also seen when mitochondria become un coupled, in which case the increase in oxygen con sumption (and NADH oxidation) is no longer repre sentative of an increased ADP availability. Thus, the fluorescence signal is the complex kinetic resul tant of three phenomena: rate of electron supply (glycolysis), rate of oxygen consumption (electron removal), and neuronal activity (ADP availability). Provided that experiments are performed under carefully controlled physiological conditions, most of the optical changes might then tentatively be ex plained with respect to other indices, such as rates of glucose consumption (CMRGLu) or oxygen utili zation (CMRo2).
Effects of pentobarbital
Our experiments demonstrate that the intraperi toneal administration of pentobarbital induced sus tained changes in the mitochondrial redox signal. However, these changes were somewhat obscured by the relatively large interanimal variability. These variations are likely to be due to the great scatter in brain pentobarbital concentrations observed in dif ferent rats following intraperitoneal administration of this drug (Crane et aI. , 1978) . The initial meta bolic effect of pentobarbital was to induce an NAD reduction that occurred simultaneously with the decrease in cerebral blood volume. The most likely explanation for the increase in the fluorescence signal is a mismatch between rates of oxygen and glucose consumption, and thus, pentobarbital might initially decrease cerebral oxygen consump tion (possibly by decreasing the neuronal firing rate), glucose utilization remaining unchanged or being decreased, although to a lesser degree. Thereafter, a clear oxidation phase occurred, and it might be hypothesized that glucose utilization was then greatly reduced, the rate of glucose use be coming lower than the rate of oxygen use. In sup port of this contention, it has previously been shown that pentobarbital (50 mg/kg, i.p.) decreased glucose consumption in parietal cortex by 52% (Hawkins et aI., 1979) . Furthermore, at this dose, the effect on glucose consumption was maximum and did not increase with increasing dosages (Crane et aI., 1978) . In contrast, phenobarbital at a similar dose (50 mg/kg, i.p.) decreased cerebral oxygen consumption by only 20%, although more severe decreases were seen with increasing doses (Nilsson and Siesjo, 1975) . These findings support our con clusion that moderate doses of barbiturates have a greater effect on cerebral glucose consumption than on cerebral oxygen consumption. The situation might be completely different and a reduction signal might be found when very high doses of bar biturates are used (LaManna et aI., 1976) , as high concentrations of barbiturates have been shown to block the electron transport chain of mitochondria studied in vitro (Chance and Hollunger, 1963) .
Our experiments also demonstrate that pentobar bital decreased cerebral blood volume, an effect that might be related to the barbiturate-induced ce rebral blood flow reduction, which is a well-docu mented phenomenon (Nilsson and Siesjo, 1975; Kassel et aI. , 1980) . The fact that the decrease in cerebral blood volume occurred simultaneously with the putative decrease in cerebral oxygen con sumption (the oxidation phase) suggests a direct link between changes in cerebral oxygen use (changes in neuronal activity) and cerebral blood flow. Under the present circumstances, it is un likely that the observed changes in blood flow could be determined by the time course and magni tude of the changes in glucose use.
Effects of indomethacin
The present study shows that the infusion of in domethacin induced a dose-dependent decrease in cerebral metabolism, as indicated by an increase of the fluorescence signal. It might be hypothesized that the observed NAD+ reduction was due to a decreased oxygen consumption, analogous to that which was found after pentobarbital administration. However, there is a major difference between bar biturate and indomethacin, in that the latter never, at any time or dose, resulted in a secondary oxida tion phase. As a sustained reduction phase was ob served with indomethacin, it is probable that this agent induced a proportionally greater reduction in oxygen than in glucose use. Evidence for this exists, in that indomethacin (10 mg/kg i. v. ) signifi cantly reduced the rate of oxygen consumption by 13-17% (Pickard et aI. , 1980a; Dahlgren and Siesjo, 1981) , and furthermore, data of McCulloch and colleagues (1982) clearly indicate that indo methacin did not change the local cerebral meta bolic rate for glucose at doses up to 30 mg/kg, i.p. Thus, the conclusions drawn from fluorescence measurements substantiate and are in agreement with these previous findings.
The present study also demonstrates that indo methacin induced a dose-related decrease in cere bral blood volume, an effect that can be correlated with the well-known indomethacin-induced de crease in cerebral blood flow (Pickard and Mac Kenzie, 1973; Sakabe and Siesjo, 1979; McCulloch et aI. , 1982) .
Our kinetic measurements demonstrate that fol lowing indomethacin administration, a biphasic de crease in cerebral blood volume occurred. In spite of the fact that a very early indomethacin-induced decrease in cerebral blood flow has already been reported (Dahlgren et aI. , 1981) , we rather believe that only the second part of the biphasic decrease J Cereb Blood Flow Metab, Vol. 7, No, 3, 1987 in blood volume is attributable to the cerebrovas cular effects of indomethacin. This assumption is based on the observation that the first decrease in cerebral blood volume peaked at a time when cor rected fluorescence increased maximally and when the blood pressure decrease was the highest. We therefore suggest that this first blood volume de crease is directly related to an immediate cardio vascular effect of indomethacin. This hypothesis is further substantiated by the observation that, under pentobarbital anesthesia, the infusion of the highest dose of indomethacin only included that early met abolic phenomenon (a nonsignificant decrease in cerebral blood volume was also noted), linked to an even more severe decrease in blood pressure, and did not change blood volume or corrected fluores cence later on. Furthermore, such optical changes (decrease in blood volume, increase in corrected fluorescence) have also been observed during the transient hypotensive phase that follows the infu sion of the vasodilatatory drug papaverine (data not shown). Thus, the early indomethacin-induced op tical changes (if any) would be obscured by those linked to blood pressure changes, and the true cere brovascular effects of indomethacin can only be as sessed at 1 or 2 min after injection, when blood pressure returned to control values.
As solutions of indomethacin slightly absorb light at 366 nm and fluoresce at 450 nm (data not shown), it might have been possible that at least part of the blood volume and corrected fluorescence changes would be directly correlated to an increasing plasma and tissue indomethacin concentration. However, no changes in optical signals were de tected after the infusion of the highest dose of indo methacin in pentobarbital-anesthetized rats, with the exception of the early blood pressure-induced changes. This observation rules out the above hy pothesis, and we suggest that the decrease in cere bral blood volume appears to be correlated with the inhibition of brain metabolism (i.e. , rate of oxygen use). Nonetheless, it should be emphasized that this conclusion would not necessarily mean that the metabolic changes were responsible for the whole vascular changes, owing to the disequilibrium be tween the extent of metabolic changes and the ex tent of blood volume changes. Thus, indomethacin might induce a decrease of blood volume that is di rectly linked to the decrease of metabolism and might also possess a pure vasoconstrictory effect. Alternatively, indomethacin might constrict cere bral blood vessels through the inhibition of prosta glandin synthesis, with a possible influence of some of the prostaglandin synthesis intermediates upon cerebral metabolism. Nevertheless, our experi-ments demonstrate that the indomethacin-induced decrease in blood volume is related on a time basis to an inhibition of oxygen consumption, with little effect on glucose consumption.
It must be noted that no changes, either in me tabolism or cerebral blood volume, could be de tected in pentobarbital-anesthetized rats following indomethacin infusion, in accordance with previous studies (Dahlgren and Siesjo, 198 1; Busija and Heistad, 1983) .
Finally, the observed indomethacin-induced changes in cerebral oxidative metabolism, namely, a decreased oxygen consumption and an unchanged glucose consumption, would suggest a shift of py ruvate metabolism toward lactic acid. Although such a phenomenon would be of minor importance under normal conditions, it might aggravate the ef fects of a cerebral ischaemia (Harris et aI., 1982) .
Effects of salicylate
The changes in optical signals following salicy late infusion are different from those induced by in domethacin. At both lower doses infused (50 and 100 mg/kg), sodium salicylate decreased cerebral blood volume-these effects being much less pro nounced than those induced by indomethacin. However, previously published results have shown that in awake rats, lysine acetylsalicylate (100 mg/kg i.v.) was equipotent to indomethacin in de creasing cerebral blood flow (Quintana et aI., 1983) . In contrast, sodium salicylate in a primate study, was shown not to decrease cerebral blood flow, but rather to increase it (Pickard et aI., 1980h) . In the present study, an increase in cerebral blood volume was detected only at the highest dose: following the infusion of 300 mg/kg of salicylate.
Were one to consider that for salicylate, prosta glandin synthesis inhibition is of some importance in the vascular constriction observed, then the ap parent discrepancy between the various results de scribed above might be explained. It has been shown that acetylsalicylate-induced inhibition of cyclooxygenase was obtained, at least partly, after an irreversible modification of the enzyme due to an acetylation of the active site (Roth et aI., 1975) . Sodium salicylate cannot provoke such a chemical change and might thus be less potent as a cycloox ygenase inhibitor, such a lower potency having been demonstrated in vivo (Vane, 1971) .
However, several lines of evidence suggest that the salicylate-induced decrease in blood volume might also be obscured by a central stimulation provoked by this drug. First, even with the lower doses used (50 and 100 mg/kg), an oxidation of NADH was observed that is likely to indicate a large increase in neuronal activity and oxygen con sumption. At these same doses, an increase in arte rial Pco2 was detected. Furthermore, increasing the dose up to 300 mg/kg did not further decrease blood volume, but increased blood volume while the redox signal became reduced-a phenomenon that might imply a large increase in glucose consump tion. In pentobarbital-anesthetized rats, the infu sion of 50 and 100 mg/kg of salicylate increased both blood volume and fluorescence. Under this anesthetic regimen, in which cerebral metabolism and flow are depressed, a pharmacologically in duced central stimulation is likely to be manifest. Strictly similar metabolic and vascular changes have been detected following infusion of metham phetamine in pentobarbital-anesthetized rats (No wicki and MacKenzie, unpublished observations). Finally, a large increase in cerebral oxygen con sumption was seen in baboons after 50 and 200 mg/kg of salicylate (Pickard et al., 1980h) . Thus, so dium salicylate might possess two antagonistic properties (at least from a vascular and metabolic point of view): it might constrict cerebral blood vessels (inhibition of prostaglandin synthesis?), and it might induce a dilatation secondary to an in creased brain metabolism (central stimulation), as has been suggested by Pickard et al. (1980h) . These opposite effects would preclude any definitive con clusions being drawn concerning the effects of sa licylate on cerebral metabolism and blood flow.
